Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 828-838
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.828
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Kaplan-Meier curves of recurrence-free survival and overall survival in pancreatic cancer patients. A: Recurrence-free survival was stratified by low/high levels of HALP; B: Overall survival was stratified by low/high levels of HALP. HALP: Hemoglobin, albumin, lymphocyte, and platelet.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Recurrence-free survival and overall survival were stratified by low/high levels of haemoglobin, albumin, lymphocyte, and platelet in both female and male pancreatic cancer patients. A: Recurrence-free survivals were stratified by low/high levels of HALP (hemoglobin, albumin, lymphocyte, and platelet) in female patients. B: Overall survivals were stratified by low/high levels of HALP in female patients. C: Recurrence-free survivals were stratified by low/high levels of HALP in male patients. D: Overall survivals were stratified by low/high levels of HALP in male patients. HALP: Hemoglobin, albumin, lymphocyte, and platelet.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Recurrence-free survival and overall survival were stratified by low/high levels of haemoglobin, albumin, lymphocyte, and platelet in pancreatic cancer patients with tumour located at head and body/tail. A: Recurrence-free survival was stratified by low/high levels of HALP (hemoglobin, albumin, lymphocyte, and platelet) in patients with tumor located at head. B: Overall survival was stratified by low/high levels of HALP in patients with tumor located at head. C: Recurrence-free survival was stratified by low/high levels of HALP in patients with tumor located at body/tail. D: Overall survival was stratified by low/high levels of HALP in patients with tumor located at body/tail. HALP: Hemoglobin, albumin, lymphocyte, and platelet.